NCT00512694Recruiting
Duke Lupus Registry
Source: ClinicalTrials.gov · Last updated 8 Jan 2026
Brief summary (registry, in English)
Lupus is a systemic autoimmune disease that can present with many varied symptoms, including joint pain, fevers, kidney disease, and rashes. Lupus can affect anyone, but it is most common in younger women. The Duke Lupus Registry will collect information and blood samples from patients with lupus (systemic lupus erythematosus or cutaneous lupus) seen in the Duke Rheumatology clinics. The goal of this Registry is to understand how lupus changes over time so that we can improve the treatment of patients with lupus.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 6 Aug 2007
- Start date
- 1 Jul 2007
- Primary completion date
- 30 Jun 2028
- Lead sponsor
- Duke University
- Diseases
- Lupus (SLE)
- NCT number
- NCT00512694
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 1 Jul 2007 to the primary completion date, 30 Jun 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Inability to travel to Duke for follow-up visits
- Inability to speak English
- Not able to provide informed consent
Who the study is looking for
- Diagnosis of Systemic Lupus Erythematosus or Cutaneous Lupus
- Patient of a rheumatologist at Duke University Medical Center
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Duke University Medical Center Coordinator of this site? Confirm its status | Durham | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.